Navidea Biopharmaceuticals Inc. announced that it filed a voluntary petition for relief under Chapter 11, Subchapter V of the United States Bankruptcy Code in the U.S. Bankruptcy Court for the District of Delaware on October 1, 2025.
The filing is intended to facilitate an orderly restructuring of the company's financial obligations while allowing limited operations to continue in order to preserve value for creditors and stakeholders.
Navidea plans to use the Chapter 11 process to explore strategic alternatives, safeguard its assets, and ensure equitable treatment of its creditors.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.